Perspective Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CATX 2830 www.perspectivetherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Perspective Therapeutics, Inc.

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium - Dec 4th, 2025 5:00 am
Perspective Therapeutics to Participate in Upcoming December Conferences - Nov 20th, 2025 5:00 am
Perspective Therapeutics: Q3 Earnings Snapshot - Nov 10th, 2025 2:27 pm
Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results - Nov 10th, 2025 2:05 pm
Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates - Nov 6th, 2025 5:45 am
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - Nov 4th, 2025 3:25 pm
Perspective Therapeutics to Participate in Upcoming November Conferences - Oct 31st, 2025 5:00 am
Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Beats Revenue Estimates - Oct 29th, 2025 6:15 am
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results - Oct 24th, 2025 5:00 am
Could CATX’s New ESMO Data Reveal a Shift in Its Long-Term Oncology Innovation Strategy? - Oct 21st, 2025 12:07 am
Perspective Therapeutics Announces First Patient Dosed with PSV359 in the Second Cohort of a Phase 1/2a Study in Patients with FAP-α Positive Solid Tumors - Oct 2nd, 2025 5:00 am
Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma - Sep 15th, 2025 5:00 am
Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer - Sep 4th, 2025 5:00 am
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors - Sep 3rd, 2025 5:00 am
Perspective Therapeutics to Participate in Upcoming September Conferences - Aug 26th, 2025 5:00 am
Perspective Therapeutics: Q2 Earnings Snapshot - Aug 13th, 2025 4:50 am
Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results - Aug 13th, 2025 4:45 am
Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Aug 12th, 2025 4:05 pm
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2025 3:35 pm
Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates - Aug 5th, 2025 5:15 am